Finoriq research workspace
Anteris Technologies Global Corp. (AVR) Institutional Holdings & 13F Ownership
Anteris Technologies Global Corp., a structural heart company, develops and commercializes. Review AVR institutional holders, 13F ownership, and position changes on Finoriq.
Company Snapshot
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
- Company
- Anteris Technologies Global Corp. (AVR)
- Ticker
- AVR
- Market Cap
- $806M
- Latest Price
- $8.28
- Industry
- Industrial Specialties
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.